Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies

Brunden, Kurt R., Trojanowski, John Q., Lee, Virginia M.-Y.·2009·Nature Reviews Drug Discovery

DOI 10.1038/nrd2959

Cited by (458)

Items 101–200 of 458

Natural and synthetic bioactive inhibitors of glycogen synthase kinase
Imran Khan, Mushtaq A. Tantray, Mohammad Sarwar Alam, Hinna Hamid · 2016 · European Journal of Medicinal Chemistry
Protein Quality Control in Neurodegenerative Disease
Jason E. Gestwicki, Dan Garza · 2012 · Progress in molecular biology and translational science
Vascular pathology: Cause or effect in Alzheimer disease?
Sergio Rius‐Pérez, Ana M. Tormos, Salvador Pérez, Raquel Taléns‐Visconti · 2017 · Neurología (English Edition)
Nanoparticle-mediated approaches for Alzheimer’s disease pathogenesis, diagnosis, and therapeutics
Sajini Deepashika Hettiarachchi, Yiqun Zhou, Elif S. Seven, Madepalli Krishnappa Lakshmana, Ajeet Kumar Kaushik, Hitendra Singh Chand, Roger M. Leblanc · 2019 · Journal of Controlled Release
Hyperphosphorylation of Tau at Ser396 occurs in the much earlier stage than appearance of learning and memory disorders in 5XFAD mice
Kanno, Takeshi, Tsuchiya, Ayako, Nishizaki, Tomoyuki · 2014 · Behavioural Brain Research
Tau mutants bind tubulin heterodimers with enhanced affinity
Shana Elbaum‐Garfinkle, Garrett Cobb, Jocelyn T. Compton, Xiaohan Li, Elizabeth R. Rhoades · 2014 · Proceedings of the National Academy of Sciences
Tau-Derived-Hexapeptide 306 VQIVYK 311 Aggregation Inhibitors: Nitrocatechol Moiety as A Pharmacophore In Drug Design
Tarek Mohamed, Tuan Anh Hoang, Masoud Jelokhani‐Niaraki, Praveen P. N. Rao · 2013 · ACS Chemical Neuroscience
Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer’s Disease
Wansheng Chang, Yonghong Wang, Xiao-Tun Zhu, Chuanjie Wu · 2017 · Medical Science Monitor
Identification and Characterization of DNA Aptamers Specific for Phosphorylation Epitopes of Tau Protein
I‐Ting Teng, Xiaowei Li, Hamad Yadikar, Zhihui Yang, Long Li, Yifan Lyu, Xiaoshu Pan, Kevin Wang, Weihong Tan · 2018 · Journal of the American Chemical Society
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
Ida Manna, Selene De Benedittis, Andrea Quattrone, Domenico Maisano, Enrico Iaccino, Aldo Quattrone · 2020 · Pharmaceuticals
Development of a Scalable, High-Throughput-Compatible Assay to Detect Tau Aggregates Using iPSC-Derived Cortical Neurons Maintained in a Three-Dimensional Culture Format
X. Medda, Liesbeth Mertens, S. Versweyveld, Annick Diels, Luanda Barnham, Alexis Bretteville, Arjan Buist, A. Verheyen, Ines E. Royaux, Andreas Ebneth et al. · 2016 · SLAS DISCOVERY
Mesenchymal stem cells rescue the Alzheimer's disease cell model from cell death induced by misfolded truncated tau
Norbert Žilka, Monika Žilková, Zuzana Kazmerova, Marek Šarišský, Viera Cigánková, M Novák · 2011 · Neuroscience
Patología vascular: ¿causa o efecto en la enfermedad de Alzheimer?
Sergio Rius‐Pérez, Ana M. Tormos, Salvador Pérez, Raquel Taléns‐Visconti · 2015 · Neurología
l -Theanine attenuates cadmium-induced neurotoxicity through the inhibition of oxidative damage and tau hyperphosphorylation
Peiling Ben, Zhengping Zhang, Yanyan Zhu, Aiying Xiong, Yanhong Gao, Jianyun Mu, Zhimin Yin, Lan Luo · 2016 · NeuroToxicology
A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration
Iijima-Ando, Kanae, Zhao, LiJuan, Gatt, Anthony, Shenton, Christopher, Iijima, Koichi · 2010 · Human Molecular Genetics
Corticotropin-releasing factor overexpression gives rise to sex differences in Alzheimer’s disease-related signaling
Debra A. Bangasser, Hongxin Dong, J Carroll, Zach Plona, Hua Ding, L Rodriguez, Chris G. McKennan, John G. Csernansky, Steven H. Seeholzer, Rita J. Valentino · 2016 · Molecular Psychiatry
Metal-involved theranostics: An emerging strategy for fighting Alzheimer’s disease
Xiaohui Wang, Xiaoyong Wang, Zijian Guo · 2018 · Coordination Chemistry Reviews
GSK-3β and its Inhibitors in Alzheimer's Disease: A Recent Update
Swapnil K. Sharma, Neha Chauhan, Swati Paliwal, Smita Jain, Kanika Verma, Sarvesh Paliwal · 2022 · Mini-Reviews in Medicinal Chemistry
RNAi medicine for the brain: progresses and challenges
Ryan L. Boudreau, Edgardo Rodríguez-Lebrón, Beverly L. Davidson · 2011 · Human Molecular Genetics
CRMP2 Hyperphosphorylation is Characteristic of Alzheimer's Disease and not a Feature Common to Other Neurodegenerative Diseases
Ritchie Williamson, Lidy van Aalten, David M. A. Mann, Bettina Platt, Florian Plattner, Lynn Bedford, John Mayer, David R Howlett, Alessia Usardi, Calum D. Sutherland et al. · 2011 · Journal of Alzheimer s Disease
CSF p-Tau levels in the prediction of Alzheimer's disease
Ramesh J. L. Kandimalla, Sudesh K. Prabhakar, Willayat Yousuf Wani, Alka Kaushal, Nidhi Gupta, Deep Raj Sharma, V. Grover, Neerja Bhardwaj, Kajal Jain, Kiran Dip Gill · 2013 · Biology Open
Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer’s Disease
Yijun Xu, Ngan Pan Bennett Au, Chi Him Eddie Ma · 2022 · Frontiers in Aging Neuroscience
Microtubule-Stabilizing Drugs from Marine Sponges: Focus on Peloruside A and Zampanolide
John Holmes Miller, A. Jonathan Singh, Peter T. Northcote · 2010 · Marine Drugs
GSPE interferes with tau aggregation in vivo: implication for treating tauopathy
Ismael Santa‐María, Carmen Díaz-Ruiz, Hanna Ksiȩżak-Reding, Alice P. Chen, Lap Ho, Jun Wang, Giulio Maria Pasinetti · 2011 · Neurobiology of Aging
Characterization of Brain-Penetrant Pyrimidine-Containing Molecules with Differential Microtubule-Stabilizing Activities Developed as Potential Therapeutic Agents for Alzheimer’s Disease and Related Tauopathies
Jane Kovalevich, Anne‐Sophie Cornec, Yuemang Yao, Michael James, Alex Crowe, V. M.- Y. Lee, John Q. Trojanowski, Amos B. Smith, Carlo Ballatore, Kurt R. Brunden · 2016 · Journal of Pharmacology and Experimental Therapeutics
Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies
Chih Hung Lo, Colin Kin‐Wye Lim, Zhipeng Ding, Sanjula P. Wickramasinghe, Anthony R. Braun, Karen H. Ashe, Elizabeth R. Rhoades, David Dale Thomas, Jonathan N. Sachs · 2019 · Alzheimer s & Dementia
Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies
Marcus Pickhardt, Thomas Neumann, Daniel Schwizer, Kari Callaway, Michele Vendruscolo, Dale Schenk, Peter St George‐Hyslop, Eva‐Maria Mandelkow, Christopher Martin Dobson, Lisa McConlogue et al. · 2015 · Current Alzheimer Research
Rescue of neurons from undergoing hallmark tau-induced Alzheimer's disease cell pathologies by the antimitotic drug paclitaxel
Or A. Shemesh, Micha E. Spira · 2011 · Neurobiology of Disease
Blood-based immunoassay of tau proteins for early diagnosis of Alzheimer's disease using surface plasmon resonance fiber sensors
Truong Thi Vu Nu, Nhu Hoa Thi Tran, Eunjoo Nam, Tan Tai Nguyen, Won Jung Yoon, Sungbo Cho, Jungsuk Kim, Keun-A Chang, Heongkyu Ju · 2018 · RSC Advances
Hydrophobic tagging-mediated degradation of Alzheimer's disease related Tau
Gao, Na, Chu, Ting-Ting, Li, Qian-Qian, Lim, Yeh-Jun, Qiu, Tian, Ma, Meng-Rong, Hu, Zhi-Wen, Yang, Xi-Fei, Chen, Yong-Xiang, Zhao, Yu-Fen et al. · 2017 · RSC Advances
Physiological clearance of tau in the periphery and its therapeutic potential for tauopathies
Jun Wang, Wang‐Sheng Jin, Xian‐Le Bu, Fan Zeng, Zhilin Huang, Weiwei Li, Lin‐Lin Shen, Zhen‐Qian Zhuang, Yuqiang Fang, Bin‐Lu Sun et al. · 2018 · Acta Neuropathologica
Strategies, Development, and Pitfalls of Therapeutic Options for Alzheimer's Disease
Christopher Haas · 2012 · Journal of Alzheimer s Disease
Targeting Aggrephagy for the Treatment of Alzheimer’s Disease
Sandeep Malampati, Ju‐Xian Song, Benjamin Chun‐Kit Tong, Anusha Nalluri, Chuanbin Yang, Ziying Wang, Sravan Gopalkrishnashetty Sreenivasmurthy, Zhou Zhu, Jia Liu, Cheng-Fu Su et al. · 2020 · Cells
Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia
Geoffrey A. Kerchner, Maria Carmela Tartaglia, Adam L. Boxer · 2011 · Expert Review of Neurotherapeutics
Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17
Bernardino Francesco Ghetti, Zbigniew K. Wszołek, Bradley F. Boeve, Salvatore Spina, Michel Goedert · 2011 · Wiley eBooks
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier)
Adam L. Boxer, Michael Gold, Edward D. Huey, William T. Hu, Howard J. Rosen, Joel H. Kramer, Fen‐Biao Gao, Edward A. Burton, Tiffany W. Chow, Aimee W. Kao et al. · 2012 · Alzheimer s & Dementia
Anthocyanins Extracted from Aronia melanocarpa Protect SH-SY5Y Cells against Amyloid-beta (1–42)-Induced Apoptosis by Regulating Ca2+ Homeostasis and Inhibiting Mitochondrial Dysfunction
Lingshuai Meng, Guang Xin, Bin Li, Dongnan Li, Xiyun Sun, Tingcai Yan, Li Li, Lin Shi, Sen Cao, Xianjun Meng · 2018 · Journal of Agricultural and Food Chemistry
Early Growth Response 1 (Egr-1) Regulates Phosphorylation of Microtubule-associated Protein Tau in Mammalian Brain
Yifan Lu, Tong Li, Hamid Y. Qureshi, Dong Cho Han, Hemant K. Paudel · 2011 · Journal of Biological Chemistry
Potential Future Neuroprotective Therapies for Neurodegenerative Disorders and Stroke
Rawan M. Tarawneh, James E. Galvin · 2010 · Clinics in Geriatric Medicine
Ferroptosis: underlying mechanisms and involvement in neurodegenerative diseases
Yi Wang, HongJing Li, QianXiong He, Rong Zou, JinRui Cai, Lin Zhang · 2023 · APOPTOSIS
The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau
Jean‐Philippe Courade, Henrik Zetterberg, Günter U. Höglinger, Ilse Dewachter · 2025 · Cell
Glycosaminoglycans, Protein Aggregation and Neurodegeneration
Dulce Papy-García, Morin Christophe, Minh Bao Huynh, Fernando Siñeriz, Ludmilla Sissoëff, Julia Elisa Sepulveda-Diaz, Rita Raisman‐Vozari · 2011 · Current Protein and Peptide Science
Wnt5a evokes cortical axon outgrowth and repulsive guidance by tau mediated reorganization of dynamic microtubules
Li Li, Thomas Fothergill, B. Ian Hutchins, Erik W. Dent, Katherine Kalil · 2013 · Developmental Neurobiology
Glycogen synthase kinase-3β activation mediates rotenone-induced cytotoxicity with the involvement of microtubule destabilization
Haruyuki Hongo, Takeshi Kihara, Toshiaki Kume, Yasuhiko Izumi, Tetsuhiro Niidome, Hachiro Sugimoto, Akinori Akaike · 2012 · Biochemical and Biophysical Research Communications
Discovery of Brain-Penetrant, Orally Bioavailable Aminothienopyridazine Inhibitors of Tau Aggregation
Carlo Ballatore, Kurt R. Brunden, Francesco Piscitelli, Michael J. James, Alex Crowe, Yuemang Yao, Edward G. Hyde, John Q. Trojanowski, Virginia M.‐Y. Lee, Amos B. Smith · 2010 · Journal of Medicinal Chemistry
Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
Vishruti S. Makani, Bin Zhang, Heeoon Han, Yuemang Yao, Pierrik Lassalas, Kevin Lou, Ian Paterson, Virginia M.‐Y. Lee, John Q. Trojanowski, Carlo Ballatore et al. · 2016 · Acta Neuropathologica Communications
Puromycin-sensitive aminopeptidase (PSA/NPEPPS) impedes development of neuropathology in hPSA/TAUP301L double-transgenic mice
Lili C. Kudo, Liubov V. Parfenova, Guijie Ren, Nancy Vi, Maria Po-Ping Hui, Zhongcai Ma, Kimbley Lau, Michelle Gray, Fawzia Bardag‐Gorce, Martina Wiedau‐Pazos et al. · 2011 · Human Molecular Genetics
The Natural Product Curcumin as a Potential Coadjuvant in Alzheimer's Treatment
Morales, Inelia, Cerda-Troncoso, Cristóbal, Andrade, Víctor, Maccioni, Ricardo B. · 2017 · Journal of Alzheimer s Disease
Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease
Sophie Laurent, Mohammad Reza Ejtehadi, Meisam Rezaei, Patrick G. Kehoe, Morteza Mahmoudi · 2012 · RSC Advances
Probing the ATP-Binding Pocket of Protein Kinase DYRK1A with Benzothiazole Fragment Molecules
Ulli Rothweiler, Wenche Stensen, Bjørn Olav Brandsdal, Johan Mattias Isaksson, Frederick Leeson, Richard Alan Engh, John S. M. Svendsen · 2016 · Journal of Medicinal Chemistry
Generation of a human induced pluripotent stem cell–based model for tauopathies combining three microtubule‐associated protein TAU mutations which displays several phenotypes linked to neurodegeneration
Juan Antonio García‐León, Alfredo Cabrera‐Socorro, Kristel Eggermont, Ann Swijsen, Joke Terryn, Raheem Fazal, Fatemeharefeh Nami, Laura Ordovás, Ana Quiles‐Jiménez, Frederic Lluís et al. · 2018 · Alzheimer s & Dementia
Unsaturated mannuronate oligosaccharide ameliorates β‐amyloid pathology through autophagy in Alzheimer’s disease cell models
Decheng Bi, Lijun Yao, Zhijian Lin, Lianli Chi, Hui Li, Hong Yuan Xu, Xiubo Du, Qiong Liu, Zhangli Hu, Jun Lu et al. · 2020 · Carbohydrate Polymers
Brain metabolism and Alzheimer's disease: The prospect of a metabolite-based therapy
Sean C. Thomas, Azhar A. Alhasawi, Vasu D. Appanna, C. Auger, Vasu D. Appanna · 2014 · The journal of nutrition health & aging
Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium
Seripa, Davide, Solfrizzi, Vincenzo, Imbimbo, Bruno P., Daniele, Antonio, Santamato, Andrea, Lozupone, Madia, Zuliani, Giovanni, Greco, Antonio, Logroscino, Giancarlo, Panza, Francesco · 2016 · Expert Review of Neurotherapeutics
New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease
Miguel Medina, Jesús Ávila · 2013 · Expert Opinion on Therapeutic Targets
Biomarkers in the Diagnosis and Prognosis of Alzheimer’s Disease
Cole Schaffer, Nakia Sarad, Ashton DeCrumpe, Disha Goswami, Sara Herrmann, Jose Morales, Parth Patel, Jim Osborne · 2014 · SLAS TECHNOLOGY
Nanomaterial-based Optical and Electrochemical Biosensors for Amyloid beta and Tau: Potential for early diagnosis of Alzheimer’s Disease
Le Minh Tu Phan; Phan Le Minh Tu, Thi Xoan Hoang, Vo Thuy Anh Thu, Hoang Lan Pham, Hien T. Ngoc Le, Somasekhar R. Chinnadayyala, Jae Young Kim, Sang-Myung Lee, Won Woo Cho, Young Hyo Kim et al. · 2021 · Expert Review of Molecular Diagnostics
Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease
Raghuraj Singh, Archna Panghal, Krishna Jadhav, Ashima Thakur, Rahul Kumar Verma, Charan Singh, Manoj Goyal, Jayant Kumar, Ajay Gajanan Namdeo · 2024 · Molecular Neurobiology
New evidence on α-synuclein and Tau binding to conformation and sequence specific GCFNx01 rich DNA: Relevance to neurological disorders
K. S. Jagannatha Rao, P Vasudevaraju, Erika N. Guerrero, Muralidhar L. Hegde, TB Collen, Gabrielle B. Britton · 2012 · Journal of Pharmacy And Bioallied Sciences
Brief update on different roles of tau in neurodegeneration
Arne Ittner, Yazi Diana Ke, Janet van Eersel, Amadeus Gladbach, Jürgen Götz, Lars Matthias Ittner · 2011 · IUBMB Life
Silver nanoparticles exhibit coating and dose-dependent neurotoxicity in glutamatergic neurons derived from human embryonic stem cells
Aynun Nahar Begum, Jose Santiago Aguilar, Lourdes Elias, Yiling Hong · 2016 · NeuroToxicology
Induced Tauopathy in a Novel 3D-Culture Model Mediates Neurodegenerative Processes: A Real-Time Study on Biochips
Diana Seidel, Dana Krinke, Heinz‐Georg Jahnke, Anika Hirche, Daniel Kloß, Till G.A. Mack, Frank Striggow, Andrea Anneliese Robitzki · 2012 · PLoS ONE
Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer’s disease
Stancu, Ilie‐Cosmin, Ris, Laurence, Vasconcelos, Bruno, Marinangeli, Claudia, Goeminne, Léonie, Laporte, Vincent, Haylani, Laetitia E., Couturier, Julien, Schakman, Olivier, Gailly, Philippe et al. · 2014 · The FASEB Journal
Development of dual targeting inhibitors against aggregations of amyloid-β and tau protein
Shinichiro Fuse, Keisuke Matsumura, Yuki Fujita, Hachiro Sugimoto, Takashi Takahashi · 2014 · European Journal of Medicinal Chemistry
Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities.
Zheng, Ping, Shultz, Sandy R., Hovens, Chris M., Velakoulis, Dennis, Jones, Nigel C., O’Brien, Terence J. · 2014 · Molecular Neurobiology
Tau and TDP-43 accumulation of the basal nucleus of Meynert in individuals with cerebral lobar infarcts or hemorrhage
Hiroyuki Hatsuta, Masaki Takao, Akane Nogami, Akiko Uchino, Hiroyuki Sumikura, Tadayuki Takata, Satoru Morimoto, Kazutomi Kanemaru, Tadashi Adachi, Tomio Arai et al. · 2019 · Acta Neuropathologica Communications
Quantitative assessment of AD markers using naked eyes: point-of-care testing with paper-based lateral flow immunoassay
Liding Zhang, Xuewei Du, Ying Su, Shiqi Niu, Yanqing Li, Xiaohan Liang, Haiming Luo · 2021 · Journal of Nanobiotechnology
Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice
Sagar Gaikwad, Nicha Puangmalai, Minal Sonawane, Mauro Montalbano, Rachel Price, Malini S. Iyer, Anamika Ray, Sandra Moreno, Rakez Kayed · 2024 · Science Translational Medicine
Developing predictive CSF biomarkers—A challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine
Dorothy G. Flood, Gerard J. Marek, Michael J. Williams · 2011 · Biochemical Pharmacology
Modulation of Protein-Protein Interactions as a Therapeutic Strategy for the Treatment of Neurodegenerative Tauopathies
Carlo Ballatore, Kurt R. Brunden, John Q. Trojanowski, V. M. -Y. Lee, Amos B. Smith, Donna M. Huryn · 2010 · Current Topics in Medicinal Chemistry
An effective treatment for Alzheimer's disease must consider both amyloid and tau
Claire J. Lansdall · 2014 · Bioscience Horizons The International Journal of Student Research
Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes
Marshall S. Goodwin, Olga Sinyavskaya, Franklin Burg, Veronica O’Neal, Carolina Ceballos‐Diaz, Pedro E. Cruz, Jada M. Lewis, Benoit I. Giasson, Peter Davies, Todd Eliot Golde et al. · 2020 · Molecular Therapy
Advances in tau-based drug discovery
Wendy J. Noble, Amy M. Pooler, Diane P. Hanger · 2011 · Expert Opinion on Drug Discovery
Overexpression of 14-3-3ζ Promotes Tau Phosphorylation at Ser262 and Accelerates Proteosomal Degradation of Synaptophysin in Rat Primary Hippocampal Neurons
Hamid Y. Qureshi, Dong Cho Han, Ryen MacDonald, Hemant K. Paudel · 2013 · PLoS ONE
Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease
Chaoyun Li, Azadeh Ebrahimi, Hermann J. Schluesener · 2012 · Ageing Research Reviews
Polyphosphate Initiates Tau Aggregation through Intra- and Intermolecular Scaffolding
Sanjula P. Wickramasinghe, Justine Lempart, Hope E. Merens, Jacob Murphy, Philipp Huettemann, Ursula Jakob, Elizabeth R. Rhoades · 2019 · Biophysical Journal
The structure and phase of tau: from monomer to amyloid filament
Yifan Zeng, Jing Yang, Bailing Zhang, Meng Gao, Zhengding Su, Yongqi Huang · 2020 · Cellular and Molecular Life Sciences
Effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG) in transgenic mouse models of frontotemporal lobar degeneration and Alzheimer’s disease
Shuk Wai Ho, Yuk Tung Chanel Tsui, Ting Ting Wong, Stanley Kwok-Kuen Cheung, William Bernard Goggins, Lau Ming Yi, Kwok Kin Cheng, Larry Baum · 2013 · Translational Neurodegeneration
A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins
Priyanka Joshi, Sean Chia, Johnny Habchi, Tuomas P. J. Knowles, Christopher Martin Dobson, Michele Vendruscolo · 2016 · ACS Combinatorial Science
Oxidative stress in the neurodegenerative brain following lifetime exposure to lead in rats: Changes in lifespan profiles
Chang Feng, Sisi Liu, Fankun Zhou, Yanyan Gao, Yanshu Li, Guihua Du, Ying Chen, Huan Jiao, Jiangao Feng, Yubin Zhang et al. · 2018 · Toxicology
Data mining of high density genomic variant data for prediction of Alzheimer's disease risk
Natalia Briones, Valentin Dinu · 2012 · BMC Medical Genetics
Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer’s Disease
Shen Ning, Mehdi Jorfi, Shaun R. Patel, Doo Yeon Kim, Rudolph E. Tanzi · 2022 · Frontiers in Neuroscience
Zebrafish models of Tauopathy
Qing Bai, Edward A. Burton · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Reversibility of Tau-Related Cognitive Defects in a Regulatable FTD Mouse Model
Astrid Sydow, Ann Van der Jeugd, Fang Zheng, Tariq Ahmed, Detlef Balschun, Olga M. Petrova, Dagmar Drexler, Lepu Zhou, Gabriele M. Rune, Eckhard Mandelkow� et al. · 2011 · Journal of Molecular Neuroscience
Role of cysteines in accelerating Tau filament formation
Hariharakrishnan Chidambaram, Subashchandrabose Chinnathambi · 2020 · Journal of Biomolecular Structure and Dynamics
Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies
Jangampalli Adi Pradeepkiran, P. Hemachandra Reddy · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Novel therapeutics for Alzheimer's disease: an update.
David Bonda, Hyun Pil Lee, Hyoung‐gon Lee, Avi L. Friedlich, George L. Perry, Xiongwei Zhu, Mark A. Smith · 2010 · PubMed
Insights into the molecular interactions between aminopeptidase and amyloid beta peptide using molecular modeling techniques
Maruti Jayram Dhanavade, Kailas Dasharath Sonawane · 2014 · Amino Acids
Functional regulation of Alu element of human angiotensin-converting enzyme gene in neuron cells
Shyh-Jong Wu, Tusty‐Jiuan Hsieh, Mei‐Chuan Kuo, Mei-Lan Tsai, Ke-Li Tsai, Chun‐Hung Chen, Yuan‐Han Yang · 2013 · Neurobiology of Aging
Alpha 1-Antichymotrypsin, an Inflammatory Protein Overexpressed in the Brains of Patients with Alzheimer’s Disease, Induces Tau Hyperphosphorylation through c-Jun N-Terminal Kinase Activation
Ethika Tyagi, Tina Fiorelli, Michelle Norden, Jaya Padmanabhan · 2013 · International Journal of Alzheimer s Disease
Effects of resveratrol and morin on insoluble tau in tau transgenic mice
Kwun Chung Yu, Ping Kwan, Stanley K. K. Cheung, Amy Shuk-Wai Ho, Larry Baum · 2018 · Translational Neuroscience
Insights into the Pathophysiology of Alzheimer’s Disease and Potential Therapeutic Targets: A Current Perspective
Kesevan Rajah Kumaran, Suleiman Yunusa, Enoch Kumar Perimal, Habibah A. Wahab, Christian P. Müller, Zurina Hassan · 2022 · Journal of Alzheimer s Disease
The Effects of Soluble A.β Oligomers on Neurodegeneration in Alzheimer's Disease
Jonathan Brouillette · 2014 · Current Pharmaceutical Design
Advances with RNA interference in Alzheimer’s disease research
Weien Yuan, Shun Chen, Xuemei Ge, Yinghui Chen, Nan Lu, Zhenguo Liu · 2013 · Drug Design Development and Therapy
The Polyphenol Altenusin Inhibits in Vitro Fibrillization of Tau and Reduces Induced Tau Pathology in Primary Neurons
Sook Wern Chua, Alberto Cornejo, Janet van Eersel, Claire H. Stevens, Inmaculada Vaca, Mercedes Cueto, Michael Kassiou, Amadeus Gladbach, Alex Macmillan, Lev Lewis et al. · 2017 · ACS Chemical Neuroscience
Effects of PTEN inhibition on regulation of tau phosphorylation in an okadaic acid‐induced neurodegeneration model
Zhou Chen, Bin Chen, Wenfang Xu, Rong‐Fang Liu, Jian Yang, Chang‐Xi Yu · 2012 · International Journal of Developmental Neuroscience
Cotinine improves visual recognition memory and decreases cortical Tau phosphorylation in the Tg6799 mice
J. Alex Grizzell, Sagar P. Patel, George Emilio Barreto, Valentina Echeverrı́a · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Sevoflurane anaesthesia induces cognitive impairment in young mice through sequential tau phosphorylation
Feng Liang, Mengzhu Li, Miao Xu, Yiying Zhang, Yuanlin Dong, Sulpicio G. Soriano, Mary Ellen McCann, Guang Yang, Zhongcong Xie · 2023 · British Journal of Anaesthesia
Uncovering specificity of endogenous TAU aggregation in a human iPSC-neuron TAU seeding model
Manos, Justine D., Preiss, Christina N., Venkat, Nandini, Tamm, Joseph, Reinhardt, Peter, Kwon, Taekyung, Wu, Jessica, Winter, Allison D., Jahn, Thomas R., Yanamandra, Kiran et al. · 2022 · iScience
Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β
Giulia Povellato, Richard I. Tuxworth, Diane P. Hanger, Guy Tear · 2013 · Biology Open